Cover Image

Drug interactions of tacrolimus with letermovir and azole antifungals following hematopoietic stem cell transplantation: A retrospective observational analysis

Abstract Tacrolimus interacts with letermovir and azole antifungals, whereas letermovir has nonuniform effects on the pharmacokinetics of azole antifungals. We retrospectively investigated the interaction of tacrolimus (continuous infusion) with letermovir considering co‐administered azole antifunga...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yuri Shinogi (Author), Toshinori Hirai (Author), Miki Ishibashi (Author), Kazuko Ino (Author), Isao Tawara (Author), Takuya Iwamoto (Author)
Format:	Book
Published:	Wiley, 2023-08-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Population pharmacokinetics of letermovir following oral and intravenous administration in healthy participants and allogeneic hematopoietic cell transplantation recipients
by: Marita Prohn, et al.
Published: (2021)

New Antifungal Agents with Azole Moieties
by: Melissa Martins Teixeira, et al.
Published: (2022)

Propranolol Ameliorates the Antifungal Activity of Azoles in Invasive Candidiasis
by: Venkatesh Mayandi, et al.
Published: (2023)

Augmenting Azoles with Drug Synergy to Expand the Antifungal Toolbox
by: Aidan Kane, et al.
Published: (2022)

Rational Design of New Monoterpene-Containing Azoles and Their Antifungal Activity
by: Nikolai S. Li-Zhulanov, et al.
Published: (2023)

Current Perspectives on Letermovir and Maribavir for the Management of Cytomegalovirus Infection in Solid Organ Transplant Recipients
by: Razonable RR
Published: (2024)

The Use of Letermovir for Ganci clovi r-Res istan t Cytomegalovirus in Kidney Transplant Recipients
by: Nikolina Bašić-Jukić, et al.
Published: (2022)

Susceptibility of Susceptibility of Susceptibility of Candida Candida spp. Oral isolates for azolic spp. Oral isolates for azolic antifungals and amphotericin B
by: Vivian Fernandes Furlletti, et al.
Published: (2016)

Triazole derivatives with improved in vitro antifungal activity over azole drugs
by: Yu S, et al.
Published: (2014)

Resurgence and Repurposing of Antifungal Azoles by Transition Metal Coordination for Drug Discovery
by: Youri Cortat, et al.
Published: (2023)

Fluconazole as primary antifungal prophylaxis for pediatric hematopoietic stem cell transplant in antifungal NA ├åVE patients
by: Amit Jain, et al.
Published: (2022)

Population Pharmacokinetics and Initial Dosage Optimization of Tacrolimus in Pediatric Hematopoietic Stem Cell Transplant Patients
by: Xiao-Lin Liu, et al.
Published: (2022)

POSACONAZOLE - NEW AZOLE BROAD-SPECTRUM ANTIFUNGAL AGENT FOR PREVENTION AND TREATMENT OF INVASIVE MYCOSES
by: N.N. Klimko
Published: (2008)

POSACONAZOLE - NEW AZOLE BROAD-SPECTRUM ANTIFUNGAL AGENT FOR PREVENTION AND TREATMENT OF INVASIVE MYCOSES
by: N.N. Klimko
Published: (2008)

Population Pharmacokinetic Model Development of Tacrolimus in Pediatric and Young Adult Patients Undergoing Hematopoietic Cell Transplantation
by: Jordan T. Brooks, et al.
Published: (2021)

Biological Evaluation of Heterocycle Moiety of Some Novel azoles Derivatives as Antibacterial and Antifungal potential Agents
by: abozar roeintan
Published: (2018)

Antifungal effect of a metabolite of Pseudomonas aeruginosa LV strain on azole-resistant Candida albicans
by: Caroline Lucio Moreira, et al.
Published: (2024)

Association between cumulative cisplatin dose and reproductive and sexual functions in patients with malignant ovarian germ cell tumors treated with bleomycin, etoposide, and cisplatin therapy: a case series study
by: Miki Akasaka, et al.
Published: (2022)

Evaluation of the performance of a prior tacrolimus population pharmacokinetic kidney transplant model among adult allogeneic hematopoietic stem cell transplant patients
by: Jing Zhu, et al.
Published: (2021)

Management of Cytomegalovirus Infections in the Era of the Novel Antiviral Players, Letermovir and Maribavir
by: Jocelyne Piret, et al.
Published: (2024)

Effects of Posaconazole on Tacrolimus Population Pharmacokinetics and Initial Dose in Children With Crohn's Disease Undergoing Hematopoietic Stem Cell Transplantation
by: Xiao Chen, et al.
Published: (2022)

Population pharmacokinetics and initial dose optimization of tacrolimus in children with severe combined immunodeficiency undergoing hematopoietic stem cell transplantation
by: Xiao Chen, et al.
Published: (2022)

Azoles Synthesis, Properties, Applications and Perspectives
Published: (2021)

Combination antifungal therapy and surgery for the treatment of invasive pulmonary aspergillosis after hematopoietic stem cell transplantation
by: Tiziana Toffolutti, et al.
Published: (2011)

Influential Factors and Efficacy Analysis of Tacrolimus Concentration After Allogeneic Hematopoietic Stem Cell Transplantation in Children with β-Thalassemia Major
by: Li C, et al.
Published: (2021)

Evaluating risk factors for acute graft versus host disease in pediatric hematopoietic stem cell transplant patients receiving tacrolimus
by: Michael Phan, et al.
Published: (2021)

Antifungal activity of terrestrial Streptomyces rochei strain HF391 against clinical azole -resistant Aspergillus fumigatus
by: S Hadizadeh, et al.
Published: (2015)

CYP3A5 influences oral tacrolimus pharmacokinetics and timing of acute kidney injury following allogeneic hematopoietic stem cell transplantation
by: Nathan D. Seligson, et al.
Published: (2024)

Comparison of creatinine‐based equations for estimating renal function for digoxin dose adjustment in patients with atrial fibrillation and heart failure
by: Masahiro Sakai, et al.
Published: (2023)

Comparision of MICs of some Iranian Herbal Essences Against Azole Resistance and Azole Susceptible of Candida Albicans
by: F Katiraee, et al.
Published: (2008)

Elevation of tacrolimus concentration after administration of methotrexate for treatment of graft-versus-host disease in pediatric patients received allogeneic hematopoietic stem cell transplantation
by: Chiaki Inoue, et al.
Published: (2023)

Usefulness of limited sampling strategy for mycophenolic acid area under the curve considering postoperative days in living-donor renal transplant recipients with concomitant prolonged-release tacrolimus
by: Tomoyuki Enokiya, et al.
Published: (2017)

Atra induced hypercalcemia due to azoles
by: Juhi Mehrotra, et al.
Published: (2022)

Bioprospecting, Synergistic Antifungal and Toxicological Aspects of the Hydroxychalcones and Their Association with Azole Derivates against <i>Candida</i> spp. for Treating Vulvovaginal Candidiasis
by: Lígia de Souza Fernandes, et al.
Published: (2024)

Effects of <i>CYP3A5</i> Genotype on Tacrolimus Pharmacokinetics and Graft-versus-Host Disease Incidence in Allogeneic Hematopoietic Stem Cell Transplantation
by: Daniel N. Marco, et al.
Published: (2024)

Relationship between CYP3A5 Polymorphism and Tacrolimus Blood Concentration Changes in Allogeneic Hematopoietic Stem Cell Transplant Recipients during Continuous Infusion
by: Naoki Yoshikawa, et al.
Published: (2021)

Substrate Specificity of Human Cytochrome P450 (CYP) 2C Subfamily and Effect of Azole Antifungal Agents on CYP2C8
by: Toshiro Niwa, et al.
Published: (2016)

In Utero Hematopoietic Cell Transplantation for Hemoglobinopathies
by: Tippi C. Mackenzie
Published: (2015)

Pediatric Hematopoietic Stem Cell Transplantation
by: Gaurav Kharya, et al.
Published: (2015)

Influence of loop diuretics on denosumab-induced hypocalcaemia in osteoporosis: a retrospective observational analysis
by: Toshinori Hirai, et al.
Published: (2024)